synthesis and in vitro pharmacology of a series of histamine h2 ...

Chapter 1
41 Baumann G, Permanetter B, Wirtzfeld A, Possible value of H2-receptor agonists for
treatment of catecholamine-insensitive congestive heart failure., Pharmacol.Ther., 24,
165-177 (1984)
42 a) Buschauer A, Synthesis and in vitro pharmacology of arpromidine and related
phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.,
J.Med.Chem., 32, 1963-1970 (1990)
b) Felix SB, Buschauer A, Baumann G, Therapeutic value of H2-receptor stimulation in
congestive heart failure. Hemodynamic effects of BU-E-76, BU-E-75 and arpromidine
(BU-E-50) in comparison to impromidine., Agents Actions Suppl., 33,257-269 (1991)
43 Eriks JC, Sterk GJ, Van der Aar EM, Van Acker SABE, Van der Goot H, Timmerman
H, 4- or 5-(co-aminoalkyl)thiazoles and derivatives; new selective H2-receptor agonists,
Agents Actions Suppl., 33, 301-314 (1991)
44 Hauel N, New inotropic agents for the treatment of heart failure, In: Trends in Medicinal
Chemistry '88 (Van der Goot H, Domäny G, Pallos L, Timmerman H, Eds), Elsevier
Science Publishers, Amsterdam, 691-708 (1989)
45 Wilmshurst P, New positive inotropic substances - True inotropy or peripheral effects ?,
Z.Kardiol., 77, 103-111 (1988)
46 Brunner HR, Nussberger J, Waeber B, Inhibitors of the renin-angiotensin system.,
Arzneim.-Forsch./Drug Res., 43, 274-279 (1993)
47 Dietz R, Waas W, Süsselbeck T, Willenbrock R, Osterziel KJ, Improvement of cardiac
function by angiotensin converting enzyme inhibition: sites of action, Circ, 87, IV-108
-IV-116(1993)
48 Menard J, Anthology of the renin-angiotensin system: a one hundred reference approach
to angiotensin II antagonists, J.Hypertension, 11, S3-S11 (1993)
49 Odenthal H-J, Josephs W, Angiotensin-converting-enzym-hemmung und angina
pectoris., Dtsch.Med.Wschr., 117, 1849-1853 (1992)
50 Lee MA, Böhm M, Paul M, Ganten D, Tissue renin-angiotensin systems: their role in
cardivascular disease, Circ, 87, IV-7 - IV-13 (1993)
51 Greenlee WJ, Siegl PKS, Angiotensin / Renin modulators., Ann.Rep.Med.Chem., 27,
59-68 (1992)
52 Petrillo Jr.EW, Trippodo NC, DeForrest JM, Antihypertensive agents., Ann.Rep.Med.
Chem., 25, 51-60 (1989)
53 Furukawa Y, Kishimoto S, Nishikawa K, U.S.Patent 4340598 (1982)
54 Bovy PR,Reitz DB, Collins JT, Chamberlin TS, Olins GM, Corpus VM, McMahon
EG, Palomo MA, Koepke JP, Smits GJ, McGraw DE, Gaw JF, Nonpeptide
angiotensin II antagonists: N-phenyl-l/Z-pyrrole derivatives are angiotensin II receptor
antagonists, J.Med.Chem., 36, 101-110 (1993)
55 Ashton WT, Cantone CL, Chang LL, Hutchins SM, Strelitz RA, McCoss M, Chang
RSL, Lotti VJ, Faust KA, Chen T-B, Bunting P, Schorn TW, Kivlighn SD, Siegl
PKS, Nonpeptide angiotensin II antagonists derived from 4//-l,2,4-triazoles and 3Himidazo[l,2-£][l,2,4]triazoles,
J.Med.Chem., 36, 591-609 (1993)
30